Texas Court Won't Revisit $2M Drug License Arbitral Award
A Texas appellate court on Friday stood by its reinstatement of a $1.875 million arbitration award in a dispute over patent licensing for technology used to treat excessive human growth hormone,...To view the full article, register now.
Already a subscriber? Click here to view full article